About Us
Company Introduction
Strategic Development
Social Responsibility
Scientific Research
Innovative Layout
Innovative Field
International
Global Expansion
Cooperative Partner
Global R&D Centers
International Cooperation
Investor Relations
Information Disclosure
Corporate Governance
Stock Information
ESG
Contact us
Products Services
Product center
Product branding
Quality & Safety
News
Company News
Media Coverage
Media Inquiries
Multimedia zone
Career
Talent
R&D Team
Employee Life
Job Opportunities
EN
CN
About Us
· Company Introduction
· Strategic Development
· Social Responsibility
Scientific Research
· Innovative Layout
· Innovative Field
Products Services
· Product center
· Product branding
· Quality & Safety
News
· Company News
· Media Coverage
· Media Inquiries
· Multimedia zone
Vocational
· Concept about Talent
· R&D Team
· Employee Life
· Job Opportunities
>
News
>
Company
Return
2024 Grand Pharma Annual Report
2025-05-06
Prev
Next
Related news
The World’s First Nasal Spray Product of Grand Pharma for the Treatment of Dry Eye Disease, OC-01, Achieves the First Batch of Commercial Prescriptions After Its Official Approval in Mainland China
2025-07-18
A New Indication of Grand Phamra’s Globally Innovative Radioactive Product SIR-Spheres® Y-90 Resin Microsphere Injection Is Officially Approved by the FDA Ahead of Schedule
2025-07-08
Grand Pharma’s Global Innovative Ophthalmic Drug CBT-001 Completes the Enrollment of All Patients in the International Multi-Center Phase III Clinical Trial
2025-06-05
